Regional Cancer Care Associates serves patients with a wide spectrum of blood conditions and blood disorders unrelated to cancer. We pride ourselves on our ability to offer state-of-the-art services across a wide provider network and still maintain a community-based, personalized approach to patient care. With locations in Connecticut, Maryland, and New Jersey, Regional Cancer Care Associates patients are able to receive the hematology care they need in a facility that’s close to home.
Regional Cancer Care Associates serves patients with a wide spectrum of blood conditions and blood disorders unrelated to cancer. We pride ourselves on our ability to offer state-of-the-art services across a wide provider network and still maintain a community-based, personalized approach to patient care. With locations in Connecticut, Maryland, and New Jersey, Regional Cancer Care Associates patients are able to receive the hematology care they need in a facility that’s close to home.
We’re here for you. Call us at 844-346-7222 or
Hematology covers a wide range of blood disorders caused by several factors, some of which are non-cancerous (benign). The symptoms of hematologic diseases depend on several factors, such as platelet count and iron absorption. Common symptoms of a blood disorder may include:
Several conditions can be managed through lifestyle changes and medication. Some blood disorders may only need treatment during pregnancy, while others are inherited and require routine care. Our comprehensive diagnostic testing services help our physicians determine the best course of treatment for each patient.
At Regional Cancer Care Associates, our benign hematology services cover a wide range of disorders. Common blood disorders we treat at each of our locations include the following:
Anemia is characterized by a low red blood count and is often accompanied by fatigue. This condition can stem from several issues, but common causes include iron deficiencies and chronic disease.
Hemolysis anemia, a more complex form of anemia, is caused by the breakdown of red blood cells. These types of anemia may be inherited or acquired. Common conditions include:
Usually triggered by an injury, blood clotting is the body’s natural defense against excessive bleeding. Clots form when proteins and particles in the blood (platelets) adhere together. However, certain conditions may exacerbate this natural process. Disorders include:
Often hereditary, this condition causes the body to absorb too much iron from food. Since iron is stored in the organs, too much of this mineral can lead to porphyrias and other complications.
Bleeding disorders that inhibit clotting can cause excessive bleeding after injury or surgery. These conditions may be present from birth or develop at a later stage in life. Conditions include:
Abnormal platelet function can cause issues with blood clotting, bruising, and bleeding. Thrombocytosis is a blood disorder where the body produces platelets in excess, while thrombocytopenia occurs when the body produces low amounts of platelets. Conditions include:
RCCA offers cutting-edge treatment options for every type of cancer. Our expert care teams can match you with the treatment plan that fits your needs. LEARN MORE
Improve your quality of life and learn to manage life with cancer through our integrative services. We offer several solutions to support and promote physical, mental, emotional, and spiritual health. LEARN MORE
The field of cancer treatment is constantly improving and evolving. RCCA conducts hundreds of clinical trials that can help develop new therapies and treatment plans. LEARN MORE
If you or a loved one needs treatment for a malignant blood disorder, access advanced care from Regional Cancer Care Associates. Our personalized, patient-focused hematology services extend throughout our wide provider network across CT, MD, and NJ. To schedule an appointment or learn more about our malignant hematology treatments, contact us today.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.